Menu

Filtros : "Financiamento FAPESP" "FÁRMACOS" "FCF-FBF" Limpar

Filtros

Refine with date range

  • 1

1 - 15 (15 records)

  • Artigo de periodico

    Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia (2025)

    Garnique, Anali Del Milagro Bernabe ; Carlos, Jorge Antonio Elias Godoy ; Parducci, Natalia Sudan ; Tavares, Maurício Temotheo ; Waitman, Karoline de Barros ; Lima, Keli ; Lotufo, Leticia Veras Costa; Parise Filho, Roberto ; Machado Neto, João Agostinho

    Source: Hematology, Transfusion and Cell Therapy. Unidades: ICB, FCF

    Subjects: LEUCEMIA, PRODUTOS NOVOS, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GARNIQUE, Anali Del Milagro Bernabe et al. Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy, v. 47, n. 2, p. 1-5 art. 103757, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.htct.2025.103757. Acesso em: 08 out. 2025.

    • APA

      Garnique, A. D. M. B., Carlos, J. A. E. G., Parducci, N. S., Tavares, M. T., Waitman, K. de B., Lima, K., et al. (2025). Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy, 47( 2), 1-5 art. 103757. doi:10.1016/j.htct.2025.103757

    • NLM

      Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitman K de B, Lima K, Lotufo LVC, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 1-5 art. 103757.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.htct.2025.103757

    • Vancouver

      Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitman K de B, Lima K, Lotufo LVC, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 1-5 art. 103757.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.htct.2025.103757

  • Artigo de periodico

    Firocoxib nanocrystals: preparation, characterization, and pharmacokinetics in beagle dogs (2025)

    Macedo, Luiza de Oliveira ; Silva, Rosana Pereira da ; Jesus, Daniel Felipe Freitas de ; Bragard, André Sampaio; Araujo, Gabriel Lima Barros de ; Ferraz, Humberto Gomes ; Ishida, Kelly ; Bou-Chacra, Nadia Araci

    Source: International Journal of Pharmaceutics. Unidades: FCF, ICB

    Subjects: MICROBIOLOGIA, ANTI-INFLAMATÓRIOS, FARMACOCINÉTICA, ABSORÇÃO (FISIOLOGIA), FÁRMACOS, DOR, NANOPARTÍCULAS, CÃES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MACEDO, Luiza de Oliveira et al. Firocoxib nanocrystals: preparation, characterization, and pharmacokinetics in beagle dogs. International Journal of Pharmaceutics, v. 679, p. 15 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2025.125756. Acesso em: 08 out. 2025.

    • APA

      Macedo, L. de O., Silva, R. P. da, Jesus, D. F. F. de, Bragard, A. S., Araujo, G. L. B. de, Ferraz, H. G., et al. (2025). Firocoxib nanocrystals: preparation, characterization, and pharmacokinetics in beagle dogs. International Journal of Pharmaceutics, 679, 15 . doi:10.1016/j.ijpharm.2025.125756

    • NLM

      Macedo L de O, Silva RP da, Jesus DFF de, Bragard AS, Araujo GLB de, Ferraz HG, Ishida K, Bou-Chacra NA. Firocoxib nanocrystals: preparation, characterization, and pharmacokinetics in beagle dogs [Internet]. International Journal of Pharmaceutics. 2025 ; 679 15 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2025.125756

    • Vancouver

      Macedo L de O, Silva RP da, Jesus DFF de, Bragard AS, Araujo GLB de, Ferraz HG, Ishida K, Bou-Chacra NA. Firocoxib nanocrystals: preparation, characterization, and pharmacokinetics in beagle dogs [Internet]. International Journal of Pharmaceutics. 2025 ; 679 15 .[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2025.125756

  • Artigo de periodico

    Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis (2025)

    Crivilari, Victória Aparecida Vit; Santos, Jean Bispo dos; Lourenço, Felipe Rebello

    Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: FÁRMACOS, ANTI-INFLAMATÓRIOS, MEDIÇÃO DE RISCO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CRIVILARI, Victória Aparecida Vit e SANTOS, Jean Bispo dos e LOURENÇO, Felipe Rebello. Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis, v. 255, p. 1-7 art. 116660, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2025.116660. Acesso em: 08 out. 2025.

    • APA

      Crivilari, V. A. V., Santos, J. B. dos, & Lourenço, F. R. (2025). Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis, 255, 1-7 art. 116660. doi:10.1016/j.jpba.2025.116660

    • NLM

      Crivilari VAV, Santos JB dos, Lourenço FR. Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2025 ; 255 1-7 art. 116660.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.jpba.2025.116660

    • Vancouver

      Crivilari VAV, Santos JB dos, Lourenço FR. Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2025 ; 255 1-7 art. 116660.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.jpba.2025.116660

  • Artigo de periodico

    Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions (2023)

    Yukuyama, Megumi Nishitani ; Zuo, Jieyu; Park, Chulhun; Yousef, Malaz ; Henostroza, Mirla Anali Bazan; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: FÁRMACOS, ANTI-HELMÍNTICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, v. 632, p. 1-9 art. 122554, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122554. Acesso em: 08 out. 2025.

    • APA

      Yukuyama, M. N., Zuo, J., Park, C., Yousef, M., Henostroza, M. A. B., Araujo, G. L. B. de, et al. (2023). Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, 632, 1-9 art. 122554. doi:10.1016/j.ijpharm.2022.122554

    • NLM

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554

    • Vancouver

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554

  • Artigo de periodico

    Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats (2023)

    Souza, Aline de ; Almeida, Maria Karilly Lima de; Barbosa, João Antonio; Yukuyama, Megumi Nishitani ; Correia, Cristiano de Jesus; Faloppa, Ana Cristina Breithaupt ; Bou-Chacra, Nadia Araci ; Calixto, Leandro Augusto

    Source: Chemistry Africa. Unidades: FM, FCF

    Subjects: TRYPANOSOMA CRUZI, FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOUZA, Aline de et al. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, v. 6, p. 837-843, 2023Tradução . . Disponível em: https://doi.org/10.1007/s42250-022-00547-6. Acesso em: 08 out. 2025.

    • APA

      Souza, A. de, Almeida, M. K. L. de, Barbosa, J. A., Yukuyama, M. N., Correia, C. de J., Faloppa, A. C. B., et al. (2023). Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, 6, 837-843. doi:10.1007/s42250-022-00547-6

    • NLM

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s42250-022-00547-6

    • Vancouver

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2025 out. 08 ] Available from: https://doi.org/10.1007/s42250-022-00547-6

  • Artigo de periodico

    Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines (2023)

    Caffaro, Arthur Massabki; Lourenço, Felipe Rebello

    Source: Chemometrics and Intelligent Laboratory Systems. Unidade: FCF

    Assunto: FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CAFFARO, Arthur Massabki e LOURENÇO, Felipe Rebello. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, v. 241, p. 1-9 art. 104935, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.chemolab.2023.104935. Acesso em: 08 out. 2025.

    • APA

      Caffaro, A. M., & Lourenço, F. R. (2023). Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, 241, 1-9 art. 104935. doi:10.1016/j.chemolab.2023.104935

    • NLM

      Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935

    • Vancouver

      Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935

  • Artigo de periodico

    Absorption matters: a closer look at popular oral bioavailability rules for drug approvals (2023)

    Trossini, Gustavo Henrique Goulart ; Soares, Artur Caminero Gomes ; Sousa, Gustavo Henrique Marques; Calil, Raisa Ludmila

    Source: Molecular informatics. Unidade: FCF

    Subjects: FÁRMACOS, ABSORÇÃO, BIODISPONIBILIDADE

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TROSSINI, Gustavo Henrique Goulart et al. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals. Molecular informatics, v. 42, n. 11, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1002/minf.202300115. Acesso em: 08 out. 2025.

    • APA

      Trossini, G. H. G., Soares, A. C. G., Sousa, G. H. M., & Calil, R. L. (2023). Absorption matters: a closer look at popular oral bioavailability rules for drug approvals. Molecular informatics, 42( 11), 1-12. doi:10.1002/minf.202300115

    • NLM

      Trossini GHG, Soares ACG, Sousa GHM, Calil RL. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals [Internet]. Molecular informatics. 2023 ; 42( 11): 1-12.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/minf.202300115

    • Vancouver

      Trossini GHG, Soares ACG, Sousa GHM, Calil RL. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals [Internet]. Molecular informatics. 2023 ; 42( 11): 1-12.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/minf.202300115

  • Artigo de periodico

    Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years (2023)

    Vassiliades, Sandra Valeria ; Navarausckas, Vitor Bastos; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto

    Source: Biointerface Research in Applied Chemistry. Unidades: ICB, FCF

    Subjects: TUBERCULOSE, FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS, MICROBIOLOGIA, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VASSILIADES, Sandra Valeria et al. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, v. 13, n. 1 p. 1-20 art. 79, 2023Tradução . . Disponível em: https://doi.org/10.33263/BRIAC131.079. Acesso em: 08 out. 2025.

    • APA

      Vassiliades, S. V., Navarausckas, V. B., Dias, M. V. B., & Parise Filho, R. (2023). Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, 13( 1 p. 1-20 art. 79). doi:10.33263/BRIAC131.079

    • NLM

      Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2025 out. 08 ] Available from: https://doi.org/10.33263/BRIAC131.079

    • Vancouver

      Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2025 out. 08 ] Available from: https://doi.org/10.33263/BRIAC131.079

  • Artigo de periodico

    Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data (2022)

    Bezzon, Vinícius Danilo Nonato ; Pinto, Rogério da Silva; Araujo, Gabriel Lima Barros de ; Lima, João Cardoso de ; Ferreira, Fábio Furlan

    Source: Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: FÁRMACOS, MÉTODO DE MONTE CARLO, BIODISPONIBILIDADE

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BEZZON, Vinícius Danilo Nonato et al. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data. Journal of Pharmaceutical Sciences, v. 111, n. 11, p. 3054-3063, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2022.06.018. Acesso em: 08 out. 2025.

    • APA

      Bezzon, V. D. N., Pinto, R. da S., Araujo, G. L. B. de, Lima, J. C. de, & Ferreira, F. F. (2022). Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data. Journal of Pharmaceutical Sciences, 111( 11), 3054-3063. doi:10.1016/j.xphs.2022.06.018

    • NLM

      Bezzon VDN, Pinto R da S, Araujo GLB de, Lima JC de, Ferreira FF. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data [Internet]. Journal of Pharmaceutical Sciences. 2022 ; 111( 11): 3054-3063.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.xphs.2022.06.018

    • Vancouver

      Bezzon VDN, Pinto R da S, Araujo GLB de, Lima JC de, Ferreira FF. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data [Internet]. Journal of Pharmaceutical Sciences. 2022 ; 111( 11): 3054-3063.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.xphs.2022.06.018

  • Artigo de jornal-dep/entr

    Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] (2022)

    Araujo, Gabriel Lima Barros de

    Source: Agência FAPESP. Unidade: FCF

    Subjects: FÁRMACOS, RADIAÇÃO SINCROTRON, DISPERSÃO DA LUZ

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ARAUJO, Gabriel Lima Barros de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler]. Agência FAPESP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP. Acesso em: 08 out. 2025. , 2022

    • APA

      Araujo, G. L. B. de. (2022). Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler]. Agência FAPESP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.

    • NLM

      Araujo GLB de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] [Internet]. Agência FAPESP. 2022 ;08 fe 2022. on-line[citado 2025 out. 08 ] Available from: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.

    • Vancouver

      Araujo GLB de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] [Internet]. Agência FAPESP. 2022 ;08 fe 2022. on-line[citado 2025 out. 08 ] Available from: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.

  • Trabalho de evento-resumo

    Adverse drug events in an intensive care unit: a pilot study using the global trigger tool (2022)

    Souza, R. N. D; Moriel, Patricia ; Ventura, Deise de Souza; Perroud Junior, Mauricio Wesley ; Visacri, Marília Berlofa

    Source: Abstracts. Conference titles: ISoP Annual Meeting "A New Era of Pharmacovigilance: Challenges and Opportunities". Unidade: FCF

    Subjects: FÁRMACOS, FARMACOVIGILÂNCIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOUZA, R. N. D et al. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. 2022, Anais.. London: International Society of Pharmacovigilance/ISOP, 2022. . Acesso em: 08 out. 2025.

    • APA

      Souza, R. N. D., Moriel, P., Ventura, D. de S., Perroud Junior, M. W., & Visacri, M. B. (2022). Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. In Abstracts. London: International Society of Pharmacovigilance/ISOP.

    • NLM

      Souza RND, Moriel P, Ventura D de S, Perroud Junior MW, Visacri MB. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. Abstracts. 2022 ;[citado 2025 out. 08 ]

    • Vancouver

      Souza RND, Moriel P, Ventura D de S, Perroud Junior MW, Visacri MB. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. Abstracts. 2022 ;[citado 2025 out. 08 ]

  • Artigo de periodico

    Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations (2022)

    Prieto, Diego Campos ; Araujo, Renan Vinicius de ; Lima, Sara de Souza; Assad, Felipe Zauith; Grayson, Scott M; Braga, Ataualpa Albert Carmo ; Lourenço, Felipe Rebello ; Giarolla, Jeanine

    Source: Journal of Molecular Structure. Unidades: IQ, FCF

    Subjects: TUBERCULOSE, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PRIETO, Diego Campos et al. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, v. 1254, p. 1-7 art. 132323, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.molstruc.2021.132323. Acesso em: 08 out. 2025.

    • APA

      Prieto, D. C., Araujo, R. V. de, Lima, S. de S., Assad, F. Z., Grayson, S. M., Braga, A. A. C., et al. (2022). Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, 1254, 1-7 art. 132323. doi:10.1016/j.molstruc.2021.132323

    • NLM

      Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323

    • Vancouver

      Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323

  • Artigo de periodico

    Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review (2022)

    Reyes, Pia Loren ; Saavedra, Nicolás ; Torso, Nadine de Godoy ; Visacri, Marília Berlofa ; Moriel, Patricia ; Salazar, Luis Antônio

    Source: Frontiers in Pharmacology. Unidade: FCF

    Subjects: FÁRMACOS, MICRORNAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      REYES, Pia Loren et al. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, v. 13, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.831099. Acesso em: 08 out. 2025.

    • APA

      Reyes, P. L., Saavedra, N., Torso, N. de G., Visacri, M. B., Moriel, P., & Salazar, L. A. (2022). Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, 13, 1-19. doi:10.3389/fphar.2022.831099

    • NLM

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2022.831099

    • Vancouver

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2022.831099

  • Artigo de periodico

    Insights into newly approved drugs from a medicinal chemistry perspective (2021)

    Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart

    Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF

    Assunto: FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 08 out. 2025.

    • APA

      Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328

    • NLM

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/1389557521666210226145328

    • Vancouver

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/1389557521666210226145328

  • Artigo de periodico

    Measurement uncertainty evaluation and risk of false conformity assessment for microbial enumeration tests (2021)

    Dias, Francielle Regina Silva; Lourenço, Felipe Rebello

    Source: Journal of Microbiological Methods. Unidade: FCF

    Subjects: MEDICAMENTO TÓPICO, FÁRMACOS, PLANEJAMENTO DE FÁRMACOS, MEDIÇÃO DE RISCO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DIAS, Francielle Regina Silva e LOURENÇO, Felipe Rebello. Measurement uncertainty evaluation and risk of false conformity assessment for microbial enumeration tests. Journal of Microbiological Methods, v. 189, p. 1-7 art. 106312, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.mimet.2021.106312. Acesso em: 08 out. 2025.

    • APA

      Dias, F. R. S., & Lourenço, F. R. (2021). Measurement uncertainty evaluation and risk of false conformity assessment for microbial enumeration tests. Journal of Microbiological Methods, 189, 1-7 art. 106312. doi:10.1016/j.mimet.2021.106312

    • NLM

      Dias FRS, Lourenço FR. Measurement uncertainty evaluation and risk of false conformity assessment for microbial enumeration tests [Internet]. Journal of Microbiological Methods. 2021 ; 189 1-7 art. 106312.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.mimet.2021.106312

    • Vancouver

      Dias FRS, Lourenço FR. Measurement uncertainty evaluation and risk of false conformity assessment for microbial enumeration tests [Internet]. Journal of Microbiological Methods. 2021 ; 189 1-7 art. 106312.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.mimet.2021.106312
  • 1

1 - 15 (15 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025